CAS: 3572-43-8; Bromhexine

该化合物是六点位置的溴化活性衍生物,具有环己基(甲基)氨基甲基替代成分,该化合物对合成有机化学具有兴趣,因为它作为制造更复杂的分子的中间体,特别是在制药和农用化学研究中具有潜力.溴原子的存在会增强进一步功能化的回动性,而环己基(甲基)胺组则会产生影响组合或替代反应中的选择性的...

结构式图片

欧盟法规

REACH注册ECHA物质C&L通报REACH预注册

上下游产品

N-methylcyclohexylamine (2-amino-3,5-dibromophenyl)methanol 3,5-dibromo-2-amino benzaldehydeanilideN,N'-bisbenzilossicarbonilcistin-bis2,4-dibromo-6-(N-cicloesil-N-metil)aminometilanilide anilid°Carbometil-N-acetilcisteinato di metileS-2,4-dibromo-6-(N-cicloesil-N-metil)aminometilanilid°Carbometil-N-acetilcisteinato di metile anilideS-carbetossimetil-N-acetilcistein-2,4-dibromo-6-(N-cicloesil-N-metil)-aminometilanilide 22H25BrN2C22H25BrN2

合成工艺路线路线简述

    2-氨基-3,5-二溴苄醇 以 四氢呋喃 用作溶剂,化学反应 6.0H,反应生成溴己新
    参考文献:2-氨基-3,5-二溴苄基类中间体化合物的制备方法及其应用
    标题:2-氨基-3,5-二溴苄基类中间体化合物的制备方法及其应用
    摘要:本发明提供一种2‑氨基‑3,5‑二溴苄基类中间体化合物的制备方法,并进一步公开了该2‑氨基‑3,5‑二溴苄基类中间体化合物在制备溴己新和氨溴索中的应用;本发明采用廉价易得的原料2‑氨基‑3,5‑二溴苯甲醛,经还原得到2‑氨基‑3,5‑二溴苯甲醇,反应条件更加温和;用n'N‑羰基二咪唑活化2‑氨基‑3,5‑二溴苯甲醇的羟基生成活性酯,活性酯与n‑甲基环己胺和反式对氨基环己醇缩合反应分别得到相应产物;本发明公开的制备方法具有重现性好,工艺简单,产品纯度高,避免产生潜在基因毒杂质的优点,可以进一步提高2‑氨基‑3,5‑二溴苄基类化合物的用药安全.

    海关参考信息

    专利信息


    专利号:US-2014378538-A1
    优先权日:2011-12-14
    标 题:Methods of responding to a biothreat
    发明人:BANCEL STEPHANE
    权利人:MODERMA THERAPEUTICS INC
    摘要:The present disclosure provides for devices, in particular mobile devices, which may be used in the synthesis of modified nucleic acid molecules, in particular modified mRNA molecules. The device for making the modified nucleosides, modified nucleotides and modified nucleic acids (e.g., mRNA) disclosed herein may be mobile devices comprising at least one sample block for insertion of one or more sample vessels, a device base with electronic control units for the sample block, a voltage supply, and one or more reagent(s) for the synthesis of at least one nucleic acid.

    专利号:US-9790531-B2
    优先权日:2012-08-14
    标 题 :Enzymes and polymerases for the synthesis of RNA
    发明人:WANG YUXUN; RAMAKRISHNAN DIVAKAR; DE FOUGEROLLES ANTONIN; WHORISKEY SUSAN
    权利人:MODERNATX INC
    摘要:The invention relates to compositions and methods for the design, evolution, preparation, and/or manufacture of enzymes for use with polynucleotides, primary transcripts and mmRNA molecules.

    专利号:US-2024002331-A1
    优先权日:2022-06-08
    标 题 :Ionizable cationic lipids and lipid nanoparticles, and methods of synthesis and use thereof
    发明人:ALI MIR; BOESCH AUSTIN WAYNE; DRUMMOND DARYL CLARK; KUHLMAN WILLIAM; NIELSEN ULRIK
    权利人:TIDAL THERAPEUTICS INC
    摘要:Provided are ionizable cationic lipids and lipid nanoparticles for the delivery of nucleic acids to cells (e.g., immune cells), and methods of making and using such lipids and targeted lipid nanoparticles.

    专利号:US-2025205169-A1
    优先权日:2023-12-13
    标 题:Ionizable cationic lipids and lipid nanoparticles, and methods of synthesis and use thereof
    发明人:ALI MIR
    权利人:TIDAL THERAPEUTICS INC
    摘要:Provided are ionizable cationic lipids and lipid nanoparticles for the delivery of nucleic acids to cells (e.g., immune cells), and methods of making and using such lipids and targeted lipid nanoparticles.

    专利号:US-2015211039-A1
    优先权日:2012-08-14
    标题:Enzymes and polymerases for the synthesis of rna

    专利号:WO-2014028429-A2
    优先权日:2012-08-14
    标 题 :Enzymes and polymerases for the synthesis of rna
    天长市天佳化工科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.tianjia-chem.com
    电话: 0086 (550) 702-1925👤
    📞天长市天佳化工科技有限公司 ⚠️参考联系方式

    销售电话:0086 (550) 702-1925
    邮箱:tianjiachem@hotmail.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    安徽省滁州市天长市石梁东路388号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Deretic V, Timmins GS. Enhancement of lung levels of antibiotics by ambroxol and bromhexine. Expert Opin Drug Metab Toxicol. 2019 Mar;15(3):213-218. doi: 10.1080/17425255.2019.1578748. Epub 2019 Feb 7.
    2: Tolouian R, Mulla ZD, Jamaati H, Babamahmoodi A, Marjani M, Eskandari R, Dastan F. Effect of bromhexine in hospitalized patients with COVID-19. J Investig Med. 2023 Oct;71(7):691-699. doi: 10.1136/jim-2020-001747. 128(6):1687-1692. doi: 10.1080/13813455.2020.1788606. Epub 2020 Jul 7.

    合成参考文献


    参考文献:10.1186/2047-783x-14-s4-38
    摘要:Calkovska A, Mokra D, Calkovsky V. Lung surfactant alterations in pulmonary thromboembolism. European Journal of Medical Research. 2009 Dec 07;14(Suppl 4):38. doi: 10.1186/2047-783x-14-s4-38.
    参考文献:10.1007/s00167-011-1610-1
    摘要:Asada S, Akagi M, Mori S, Matsushita T, Hashimoto K, Hamanishi C. Increase in posterior tibial slope would result in correction loss in frontal plane after medial open-wedge high tibial osteotomy. Knee Surg Sports Traumatol Arthrosc. 2012 Mar;20(3):571–8. doi: 10.1007/s00167-011-1610-1.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知